Dissident Shareholder Goggin Wins Seat on Vermillion's Board of Directors | GenomeWeb

NEW YORK (GenomeWeb News) – Vermillion said in a US Securities and Exchange Commission filing released after the close of the market yesterday that its shareholders elected Robert Goggin to the company's board of directors at the firm's annual meeting last week.

Goggin, who was put forth as a candidate by a trio of dissident shareholders comprising himself, Gregory Novak, and George Bessenyei, defeated Vermillion's candidate, Roberta Della Vedova, with 4,749,042 votes cast for Goggin compared to 3,938,399 for Vedova.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."